This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
protein
product name :
Human HLA-C Protein (Recombinant His) - LS-G19253
catalog :
LS-G19253
quantity :
1 mg
price :
2835 USD
product information
ProteinId :
40839
CatalogNumber :
LS-G19253
Product Name :
Human HLA-C Protein (Recombinant His) - LS-G19253
Description :
HLA-C Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 307 amino acids (25-308) and having a molecular mass of 34.9kDa.HLA-C is fused to a 23 amino acid His-tag at N-terminus and purified by proprietary chromatographic techniques.
PresentationDesc :
20 mM Tris-HCl, pH 8.0, 20 mM NaCl, 20 mM DTT, 20% glycerol.
ProteinTag :
His
ProteinType :
Recombinant
ProteinSpecies :
Human
ProteinSourceSpecies :
E. coli
RecommendedStorage :
Store lyophilized at 4°C. Once reconstituted, aliquot and store at -20°C. Avoid freeze-thaw cycles.
Purification :
Greater than 90% by SDS-PAGE
PredictedMolecularWeight :
34.9 kDa
Gene :
HLA-C
StandardGeneSymbol :
HLA-C
Synonyms :
HLA-C, D6S204, HLA-JY3, HLC-C, PSORS1, HLAC
ProductID :
40839
ProductNumber :
LS-G19253-1
Weight :
1 mg
LSListPrice :
2835 USD
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
antibodies@lsbio.com
www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.